21 results
S-8
EX-4.2
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
, with the balance paid thereafter on the original schedule.
(o)Choice of Law. This Plan and any controversy arising out of or relating to this Plan shall
424B5
VKTX
Viking Therapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:13pm
Unless we provide otherwise in the applicable prospectus supplement, the warrants and warrant agreements, and any claim, controversy or dispute arising
8-K
EX-1.1
VKTX
Viking Therapeutics Inc
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
, controversy or disputes arising under or related to this Agreement and any transaction contemplated by this Agreement shall be governed
424B5
VKTX
Viking Therapeutics Inc
27 Feb 24
Prospectus supplement for primary offering
5:21pm
, the warrants and warrant agreements, and any claim, controversy or dispute arising under or related to the warrants or warrant agreements
S-3ASR
99lov or4xf
26 Jul 23
Automatic shelf registration
5:26pm
S-3ASR
EX-5.1
d60nv1p3j cz9
26 Jul 23
Automatic shelf registration
5:26pm
424B5
crq jsjn833
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
ua61d55 0yhj9l39i7
29 Mar 23
Prospectus supplement for primary offering
4:01pm
424B5
tjv 2850wcqasw
2 Aug 19
Prospectus supplement for primary offering
12:00am
424B5
9d761bhz j2
21 Sep 18
Prospectus supplement for primary offering
4:16pm
424B5
sdirr
19 Sep 18
Prospectus supplement for primary offering
4:27pm
424B5
ggzek 0fojx28fbxpckf
7 Jun 18
Prospectus supplement for primary offering
5:13pm
424B5
ilg vgacioonxgilm7
6 Jun 18
Prospectus supplement for primary offering
4:11pm